|
|
Clinical effect of Xuanyu Tongjing Decoction combined with Levonorgestrel intrauterine system in the treatment of adenomyosis with dysmenorrhea |
YUAN Yuan1 WANG Shuang1 ZHONG Hao-xiang2 ZHANG Xiao-ling1▲ LI Dong-qing1 |
1. Department of Gynecology, Jiangxi Provincial Maternal and Child Health Hospital, Nanchang 330006, China;
2. Department of Service, Jiangxi Provincial Institute of Occupational Disease Prevention and Control, Nanchang 330006, China |
|
|
Abstract Objective To explore the effect and safety of Xuanyu Tongjing Decoction combined with Levonorgestrel intrauterine system in the treatment of adenomyosis with dysmenorrhea. Methods A total of 120 adenomyosis patients with dysmenorrhea recruited in Jiangxi Provincial Maternal and Child Health Hospital from February to August 2018 were selected as the study objects and divided into control group and observation group, with 60 cases in each group based on random number table method. The observation group was treated with Xuanyu Tongjing Decoction combined with Levonorgestrel intrauterine system, and the control group was only treated with Levonorgestrel intrauterine system. The symptoms of dysmenorrhea, the degree of pain, traditional Chinese medicine (TCM) syndrome integral, the volume of uterus, the level of serum carbohydrate antigen-125 (CA-125) and the occurrence of the adverse reaction were compared after 6 months of treatment. Results The symptom score of dysmenorrhea, visual analogue scale (VAS) score,TCM syndrome integral score, uterine volume and the level of serum CA-125 level in both two groups after 6 months of treatment were higher than those before treatment, and the differences were statistically significant (P<0.05). The symptom score of dysmenorrhea, VAS score, TCM syndrome integral score, uterine volume and the level of serum CA-125 level in observation group after 6 months of treatment were lower than those in control group, and the differences were statistically significant (P<0.05). The total incidence of adverse reactions in the observation group and the control group had no statistically significant difference (P >0.05). Conclusion Xuanyu Tongjing Decoction combined with Levonorgestrel intrauterine system can effectively improve the clinical symptoms of adenomyosis with dysmenorrhea, and worthy to be promoted and applicated in clinical.
|
|
|
|
|
[1] |
涂皎,高毅,黄茂兰,等.左炔诺孕酮宫内缓释系统对子宫腺肌症患者月经及卵巢功能的影响研究[J].中国全科医学,2016,19(4):427-430.
|
[2] |
彭存旭,李景刚,郝贤华,等.腹腔镜下多术式联合治疗子宫腺肌病的临床观察[J].实用妇产科杂志,2014,30(6):475-478.
|
[3] |
陈富强,张爱凤,王小波.子宫内膜电切术联合左炔诺孕酮宫内节育系统治疗子宫腺肌病的前瞻性研究[J].上海交通大学学报(医学版),2017,37(5):641-645.
|
[4] |
吴力为.曼月乐治疗子宫腺肌症58 例疗效分析[J].江苏医药,2017,43(4):301-302.
|
[5] |
孙芯蕊.论宣郁通经汤加减治疗子宫内膜异位症痛经[J].内蒙古中医药,2017,36(13):8-9.
|
[6] |
郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.
|
[7] |
郎景和.子宫内膜异位症基础与临床研究的几个问题[J].中国实用妇科与产科杂志,2002,18(3):129-130.
|
[8] |
韩璐,李晴晴.宫腔镜技术在子宫腺肌病诊治中的应用进展[J].妇产与遗传(电子版),2017,7(1):31-35.
|
[9] |
张信美,黄秀峰,郝敏.子宫腺肌症[M].北京:人民卫生出版社,2018:361.
|
[10] |
谢幸,苟文丽,林仲秋,等.妇产科学[M].8 版.北京:人民卫生出版社,2013:273.
|
[11] |
Pontis A,D′Alterio MN,Pirarba S,et al.Adenomyosis:a systematic review of medical treatment[J].Gynecol Endocrinol,2016,32(9):696-700.
|
[12] |
茅晶晶,郑孟女,胡炳真.左炔诺孕酮宫内缓释系统治疗子宫腺肌症患者的疗效分析[J].中国临床药理学与治疗学,2017,22(10):1158-1161.
|
[13] |
金平安,尹庆卿.左炔诺孕酮宫内缓释系统治疗子宫腺肌症的疗效及安全性观察[J].中国性科学,2015,30(1):39-41.
|
[14] |
李梦如,陈欢,张红,等.GnRHa 与子宫腺肌症相关研究进展[J].中国性科学,2018,27(7):79-82.
|
[15] |
王文莉,张颖,郭银树,等.GnRHa 联合左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床疗效研究[J].医学综述,2018,24(13):2689-2692.
|
[16] |
徐晓颖,尤洁净.曼月乐治疗子宫腺肌症的临床疗效和安全性分析[J].中国妇幼保健,2017,32(13):2876-2878.
|
[17] |
Sheng J,Zhang WY,Zhang JP,et al.The LNG-IUS study on adenomyosis:a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis[J].Contraception,2009,79(3):189-193.
|
[18] |
王爽.宣郁通经汤治疗子宫腺肌症痛经的效果[J].中国当代医药,2019,26(1):190-192.
|
[19] |
魏玲,王军,张宗敏.宣郁通经汤与血府逐瘀胶囊治疗子宫内膜异位症痛经疗效观察[J].四川中医,2017,35(12):173-175.
|
[20] |
刘智衡.宣郁通经汤治疗痛经的疗效观察[J].实用中医药杂志,2016,32(11):1064-1065.
|
[21] |
曾艺文,刘耀岽.乌梅汤合宣郁通经汤加减治疗子宫腺肌症痛经的临床观察[J].中医药导报,2018,22(5):79-81.
|
|
|
|